{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:28:44Z","timestamp":1760898524252,"version":"3.41.2"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"publisher","award":["SQ2017YFSF090096"],"award-info":[{"award-number":["SQ2017YFSF090096"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","award":["Young Investigator Award 2013"],"award-info":[{"award-number":["Young Investigator Award 2013"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81300627, 81370855, 81702536, 81770756"],"award-info":[{"award-number":["81300627, 81370855, 81702536, 81770756"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.00589","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T13:32:06Z","timestamp":1588253526000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Detection of Prostatic Inflammation From Peripheral Lymphocyte Count and Free\/Total PSA Ratio in Men With LUTS\/BPH"],"prefix":"10.3389","volume":"11","author":[{"given":"Xinyang","family":"Liao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianzhong","family":"Ai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangren","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.eururo.2005.11.026","article-title":"Diclofenac for treatment of nocturia caused by nocturnal polyuria: a prospective, randomised, double-blind, placebo-controlled crossover study","volume":"49","author":"Addla","year":"2006","journal-title":"Eur. Urol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1476-5381.2012.01969.x","article-title":"Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia","volume":"167","author":"Altavilla","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/j.1464-410X.2006.06400.x","article-title":"Atherosclerosis as a risk factor for benign prostatic hyperplasia","volume":"98","author":"Berger","year":"2006","journal-title":"BJU Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s11934-014-0462-x","article-title":"Hyperglycemia and insulin resistance and the risk of BPH\/LUTS: an update of recent literature","volume":"15","author":"Breyer","year":"2014","journal-title":"Curr. Urol Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2011.03.055","article-title":"The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation","volume":"60","author":"De Nunzio","year":"2011","journal-title":"Eur. Urol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/s0302-2838(02)00548-1","article-title":"Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis","volume":"43","author":"Di Silverio","year":"2003","journal-title":"Eur. Urol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/iju.12243","article-title":"White blood cell count is positively associated with benign prostatic hyperplasia","volume":"21","author":"Fujita","year":"2014","journal-title":"Int. J. Urol"},{"key":"B8","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-84858-7","volume-title":"The elements of statistical learning: data mining, inference, and prediction","author":"Hastie","year":"2009"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1097\/00005392-199805000-00050","article-title":"Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate","volume":"159","author":"Jung","year":"1998","journal-title":"J. Urol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1464-410X.2012.11559.x","article-title":"Non-steroidal anti-inflammatory drugs for lower urinary tract symptoms in benign prostatic hyperplasia: systematic review and meta-analysis of randomized controlled trials","volume":"111","author":"Kahokehr","year":"2013","journal-title":"BJU Int."},{"key":"B11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.4111\/kju.2010.51.4.266","article-title":"The effect of intraprostatic chronic inflammation on benign prostatic hyperplasia treatment","volume":"51","author":"Kwon","year":"2010","journal-title":"Korean J. Urol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1158\/1055-9965.EPI-19-0387","article-title":"A Systematic Review and Meta-analysis of Associations between Clinical Prostatitis and Prostate Cancer: New Estimates Accounting for Detection Bias","volume":"28","author":"Langston","year":"2019","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.urology.2009.02.064","article-title":"Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia","volume":"74","author":"Liu","year":"2009","journal-title":"Urology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1046\/j.1464-410x.2001.02193.x","article-title":"Consensus development of a histopathological classification system for chronic prostatic inflammation","volume":"87","author":"Nickel","year":"2001","journal-title":"BJU Int."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.eururo.2007.11.026","article-title":"The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial","volume":"54","author":"Nickel","year":"2008","journal-title":"Eur. Urol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1159\/000448289","article-title":"Association between Benign Prostatic Hyperplasia and Neutrophil-Lymphocyte Ratio, an Indicator of Inflammation and Metabolic Syndrome","volume":"98","author":"Ozer","year":"2017","journal-title":"Urol Int."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1210\/jc.2005-2799","article-title":"Metabolic factors associated with benign prostatic hyperplasia","volume":"91","author":"Parsons","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1002\/pros.21027","article-title":"Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis","volume":"69","author":"Robert","year":"2009","journal-title":"Prostate"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/pros.21387","article-title":"Biomarkers for the diagnosis of prostatic inflammation in benign prostatic hyperplasia","volume":"71","author":"Robert","year":"2011","journal-title":"Prostate"},{"key":"B20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.juro.2007.09.083","article-title":"Prostate volume estimation using the ellipsoid formula consistently underestimates actual gland size","volume":"179","author":"Rodriguez","year":"2008","journal-title":"J. Urol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/aje\/kwp406","article-title":"Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial","volume":"171","author":"Schenk","year":"2010","journal-title":"Am. J. Epidemiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40779-019-0223-8","article-title":"Periodontal disease and risk of benign prostate hyperplasia: a cross-sectional study","volume":"6","author":"Wu","year":"2019","journal-title":"Military Med. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.eururo.2014.06.026","article-title":"Prevalence of inflammation and benign prostatic hyperplasia on autopsy in Asian and Caucasian men","volume":"66","author":"Zlotta","year":"2014","journal-title":"Eur. Urol"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00589\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T13:32:11Z","timestamp":1588253531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00589\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":23,"alternative-id":["10.3389\/fphar.2020.00589"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.00589","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2020,4,30]]},"article-number":"589"}}